• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Biotechnology
Biotechnology

... Verifies the drug’s effectiveness in its intended use Assessment of long term effects ...
Resources | PKD Foundation
Resources | PKD Foundation

... (TEMPO) Trial. Tolvaptan, a drug developed by Otsuka Pharmaceuticals, blocks the binding of the hormone vasopressin to its receptor in the kidney. Vasopressin causes production of the molecule cyclic Adenosine MonoPhosphate (cAMP) in the kidney. cAMP is thought to accelerate the progression of Autos ...
William Hellenbrand, M.D., Director of Pediatric Cardiology
William Hellenbrand, M.D., Director of Pediatric Cardiology

... grow and develop ...
2013 > Jubilant HollisterStier General Partnership 2/20/13
2013 > Jubilant HollisterStier General Partnership 2/20/13

... assure that water from other areas will not be introduced into the aseptic filling area. The violations cited in this letter are not intended to be an all-inclusive list of violations that exist at your facility. You are responsible for investigating and determining the causes of the violations iden ...
Clinical Trials PHASE 1
Clinical Trials PHASE 1

Biosafety Application, Human Gene Transfer Clinical Trials
Biosafety Application, Human Gene Transfer Clinical Trials

... Human gene transfer experiments that may require NIH RAC review in addition to the local IBC review: Check any and all that apply to this protocol: ______ The protocol uses a new vector, genetic material, or delivery methodology that represents a firstin-human experience, thus presenting an unknown ...
Development of Tamper Deterrent Formulations
Development of Tamper Deterrent Formulations

... of the outcomes of these tests were made public during FDA advisory committee meetings and conference presentations. However, little is known about the details of each manufacturer’s methods, rendering any comparison between technologies or product very difficult. Several manufacturers have also con ...
Document
Document

... probability of being unable to work, limited in work, and having ever been hospitalized, and the number of workloss days and restricted-activity days, are all inversely related to the stock of drugs (total and/or priority-review) approved 3 to 5 years earlier. • These estimates enable us to calculat ...
Post ECBS version ENGLISH ONLY EXPERT COMMITTEE ON
Post ECBS version ENGLISH ONLY EXPERT COMMITTEE ON

... account of recognized difficulties and there have also been changes in international regulatory expectations (1417). Special considerations apply to the production and control of biological medicines, including biotherapeutics, which do not apply to chemical drugs. This is because of the biological ...
Anorectics on Trial: A Half Century of Federal Regulation of
Anorectics on Trial: A Half Century of Federal Regulation of

... for phentermine and fenfluramine skyrocketed in the mid1990s (28). This revival was stimulated by the juxtaposition of a dramatic increase in the prevalence of obesity with publication of a single study in which 121 obese individuals received treatment with placebo or phentermine plus fenfluramine f ...
Food and Drug Interactions
Food and Drug Interactions

... • Extent of absorption may be greater • In stomach liquids expose drug to greater acidic degradation ...
K2, Salvia, Khat, Toad Licking and More: A Look at Some
K2, Salvia, Khat, Toad Licking and More: A Look at Some

... From the “Official K2 Website” Conditions of Use I agree that I am at least 18 years of age as of the date of purchase. I understand that K2 is not for human consumption. Under no circumstances should K2 incense be ingested, consumed or smoked. I take full liability for any damages, lost profit or ...
Anabolic Laboratories : Policosanol
Anabolic Laboratories : Policosanol

PHARMACEUTICALS: RESTRICTIONS IN USE AND AVAILABILITY
PHARMACEUTICALS: RESTRICTIONS IN USE AND AVAILABILITY

... which the regulation came into force; a summary of regulatory measures taken by governments; brief explanatory comments where necessary; and legal and bibliographical references. While the information cannot be regarded as exhaustive, either in terms of products or regulatory measures, it covers reg ...
Clinical Alert
Clinical Alert

... liver damage, adrenal insufficiency, and serious drug interactions. Since that time, 1 death due to oral ketoconazole use to treat a fungal infection of the nails has been reported. The agency is again warning healthcare professionals (HCPs) to avoid prescribing ketoconazole oral tablets for this of ...
Biopharmaceutics
Biopharmaceutics

alkermes - Moodle Lille 2
alkermes - Moodle Lille 2

Biopharmaceutics
Biopharmaceutics

... Toxicokinetic studies are performed in animals during preclinical drug development and may continue after the drug has been tested in clinical trials • Clinical toxicology is the study of adverse effects of drugs and toxic substances (poisons) in the body • The pharmacokinetics of a drug in an overm ...
Main presentation heading in one or two lines
Main presentation heading in one or two lines

... This is a true collaboration with peer-review and management from all partners ...
Bioavailability
Bioavailability

... plants) was compiled in the 1st century AD, scientific pharmacology was possible only from the 18th century on, when drugs could be purified and standardized. ...
avoid these drugs for the elderly
avoid these drugs for the elderly

... “DRUGS TO BE AVOIDED IN THE ELDERLY” and FDA DRUG EFFICACY STUDY IMPLEMENTATION “LTE” DRUGS In order to continually improve the quality of care for our members, the CareOregon Pharmacy & Therapeutics Committee voted unanimously to remove or add age restriction to the drugs listed in the tables below ...
Pharmacy Technician*s Course. LaGuardia Community College
Pharmacy Technician*s Course. LaGuardia Community College

...  Helps in inventory management in hospitals  Prepacked and unit dose blister cards by law are permitted to be return to inventory upon return  Beyond use dating BUD are one of two systems  50% of the expiration date on the manufacturer drug or 1 year whichever is sooner (my hospital uses this)  ...
PA 330 – Medical Records – Unit 2
PA 330 – Medical Records – Unit 2

... addresses basic pharmacology, different types of injuries, and related therapeutic treatments. The pharmacological topics we discuss will include prescriptions with abbreviations, drug administration, drug profiles and drug schedules, and an explanation of the actions, indications, and side effects ...
Treatment of nausea and vomiting during pregnancy
Treatment of nausea and vomiting during pregnancy

... [5HT3] receptors in the gut), which has considerably less data to support safety in pregnancy compared to the first-line antiemetics. However, the limited available data suggest that it is not associated with an increased risk of malformations. Use may be necessary in some women with severe symptoms ...
Efforts to Support the Development of Fusidic Acid in the United States
Efforts to Support the Development of Fusidic Acid in the United States

... Cempra established a business arrangement with Ercros (Ercros Industrial) to obtain a supply of FA and obtain exclusive access to this source for the US market. APPROACHING THE FDA Cempra, with hundreds of existing publications on FA, proceeded to consider a 505(b)(2) application strategy to obtain ...
< 1 ... 141 142 143 144 145 146 147 148 149 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report